• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 2 型糖尿病患者临床实践指南依从性相关的因素:西班牙德尔菲共识的结果。

Factors Associated with Adherence to Clinical Practice Guidelines for Patients with Type 2 Diabetes Mellitus: Results of a Spanish Delphi Consensus.

机构信息

Service of Endocrinology, Hospital Clínico Lozano Blesa, Zaragoza, Spain.

Service of Endocrinology, Hospital de Fuenlabrada, Madrid, Spain.

出版信息

J Diabetes Res. 2021 Oct 23;2021:9970859. doi: 10.1155/2021/9970859. eCollection 2021.

DOI:10.1155/2021/9970859
PMID:34725642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557084/
Abstract

OBJECTIVE

To assess factors associated with adherence to clinical practice guidelines (CPGs) for type 2 diabetes mellitus (T2DM).

METHODS

A cross-sectional multicenter study based on a two-round Delphi survey was designed. A total of 98 endocrinologists (mean age 45 years) involved in the care of T2DM patients completed a 43-item questionnaire assessing different aspects of adherence related to CPGs.

RESULTS

Most participants worked in tertiary care public hospitals. All participants used CPGs, with ADA/EASD as the most common (99%). The lack of time, establishment of an individualized management of patients, insufficient human resources, and therapeutic inertia were scored as the main reasons for not following CPGs recommendations. Participants agreed that insufficient material resources and limitations established by the healthcare system prevent adherence to CPGs. The risk of hypoglycemia was considered to be limiting factor for the patients' integral control. Also, there was consensus on the need to have the support of nursing personnel with specific training in diabetes as well as dietitians and podiatrists. There was disagreement regarding the influence on adherence to CPGs of patient's characteristics not matching those of CPGs, patient's preferences, tolerability of the action recommended, concomitant comorbidities, or pluripathological conditions. Differences according to the participant's age (≤40 years vs. >40 years) were not found. Therapeutic inertia and lack of time did not show a significant correlation.

CONCLUSIONS

Nonadherence to CPGs on T2DM is a multifactorial problem but the existence multiple CPGs, the lack of time, the therapeutic inertia, and insufficient human resources have been identified as factors limiting adherence. Hypoglycemia continues to be a barrier for achievement of targets recommended by CPGs.

摘要

目的

评估与 2 型糖尿病(T2DM)临床实践指南(CPGs)依从性相关的因素。

方法

设计了一项基于两轮德尔菲调查的横断面多中心研究。共有 98 名参与 T2DM 患者治疗的内分泌科医生(平均年龄 45 岁)完成了一份包含 43 个项目的问卷,评估与 CPG 相关的依从性的不同方面。

结果

大多数参与者在三级公立医院工作。所有参与者均使用 CPGs,ADA/EASD 最常用(99%)。缺乏时间、为患者建立个体化管理、人力资源不足和治疗惰性被评为不遵循 CPG 建议的主要原因。参与者一致认为,缺乏物质资源和医疗体系的限制阻碍了 CPG 的遵循。低血糖风险被认为是限制患者全面控制的因素。此外,还需要有经过专门培训的护理人员、营养师和足病医生的支持。对于患者特征与 CPG 不匹配、患者偏好、推荐行动的耐受性、共患合并症或多系统疾病对 CPG 依从性的影响存在分歧。未发现参与者年龄(≤40 岁与>40 岁)差异。治疗惰性和缺乏时间之间没有显著相关性。

结论

T2DM 不遵循 CPG 是一个多因素问题,但存在多个 CPG、缺乏时间、治疗惰性和人力资源不足已被确定为限制依从性的因素。低血糖仍然是实现 CPG 推荐目标的障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f1/8557084/75c3d760ca2a/JDR2021-9970859.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f1/8557084/50e8d6c2b027/JDR2021-9970859.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f1/8557084/75c3d760ca2a/JDR2021-9970859.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f1/8557084/50e8d6c2b027/JDR2021-9970859.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f1/8557084/75c3d760ca2a/JDR2021-9970859.002.jpg

相似文献

1
Factors Associated with Adherence to Clinical Practice Guidelines for Patients with Type 2 Diabetes Mellitus: Results of a Spanish Delphi Consensus.与 2 型糖尿病患者临床实践指南依从性相关的因素:西班牙德尔菲共识的结果。
J Diabetes Res. 2021 Oct 23;2021:9970859. doi: 10.1155/2021/9970859. eCollection 2021.
2
Relationship Between Using Clinical Practice Guidelines for Pain Treatment and Physicians' Training and Attitudes Toward Patients and the Effects on Patient Care.疼痛治疗临床实践指南的使用与医生培训、对患者的态度之间的关系及其对患者护理的影响。
Pain Pract. 2018 Jan;18(1):38-47. doi: 10.1111/papr.12579. Epub 2017 May 5.
3
Diagnosis and follow-up of patients with Hunter syndrome in Spain: A Delphi consensus.西班牙亨特综合征患者的诊断与随访:德尔菲共识
Medicine (Baltimore). 2018 Jul;97(29):e11246. doi: 10.1097/MD.0000000000011246.
4
[Control of type 2 diabetes mellitus in Spain today: identification of the main obstacles in daily clinical practice].[当今西班牙2型糖尿病的控制:日常临床实践中主要障碍的识别]
Med Clin (Barc). 2013 Sep;141 Suppl 2:3-6. doi: 10.1016/S0025-7753(13)70056-3.
5
Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study.了解基层医疗医生对2型糖尿病的筛查实践:一项定性图表激发式回忆研究
BMC Fam Pract. 2017 Apr 4;18(1):50. doi: 10.1186/s12875-017-0623-3.
6
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.血压和血脂管理在 2 型糖尿病患者中远远不足:来自包括六项德国基于人群研究的 DIAB-CORE 联盟的结果。
Cardiovasc Diabetol. 2012 May 8;11:50. doi: 10.1186/1475-2840-11-50.
7
[Advanced knowledge of patient preferences for end-of-life care in national health service hospitals of the Murcia Region].[穆尔西亚地区国民健康服务医院中患者对临终关怀偏好的先进知识]
Rev Calid Asist. 2011 May-Jun;26(3):152-60. doi: 10.1016/j.cali.2010.11.013. Epub 2011 Apr 1.
8
Knowledge and prescribing behaviour of Flemish general practitioners regarding novel glucose-lowering medications: Online cross-sectional survey.关于新型降糖药物,佛兰德全科医生的知识和处方行为:在线横断面调查。
Prim Care Diabetes. 2024 Aug;18(4):441-447. doi: 10.1016/j.pcd.2024.06.002. Epub 2024 Jun 11.
9
Management of patients with type 2 diabetes and multiple chronic conditions: A Delphi consensus of the Spanish Society of Internal Medicine.2型糖尿病合并多种慢性病患者的管理:西班牙内科医学会德尔菲共识
Eur J Intern Med. 2016 Jan;27:31-6. doi: 10.1016/j.ejim.2015.10.015. Epub 2015 Nov 14.
10
Prescriber continuity and medication adherence for complex patients.复杂患者的开方医生连续性与用药依从性。
Ann Pharmacother. 2015 Mar;49(3):293-302. doi: 10.1177/1060028014563266. Epub 2014 Dec 30.

引用本文的文献

1
Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia.开具具有心血管益处的抗糖尿病药物的障碍:克罗地亚全科医生的实践、经验和态度
BMC Prim Care. 2025 May 2;26(1):143. doi: 10.1186/s12875-025-02837-7.
2
Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care - a collaborative study with experts from Diabetes Canada.Exandra的分析验证:一种用于促进初级保健中2型糖尿病指南指导治疗的临床决策支持系统——与加拿大糖尿病协会专家的合作研究
BMC Med Inform Decis Mak. 2025 Feb 12;25(1):74. doi: 10.1186/s12911-025-02881-4.
3

本文引用的文献

1
Exercise Adherence in Hispanic Adolescents with Obesity or Type 2 Diabetes. Hispanic 青少年肥胖或 2 型糖尿病患者的运动依从性。
J Pediatr Nurs. 2021 Jan-Feb;56:7-12. doi: 10.1016/j.pedn.2020.09.012. Epub 2020 Nov 9.
2
Adoption of and adherence to the Hellenic Diabetes Association guidelines for the management of subjects with type 2 diabetes mellitus by Greek physicians.希腊医生对 2 型糖尿病患者管理的采用和坚持希腊糖尿病协会指南。
Hormones (Athens). 2021 Jun;20(2):347-358. doi: 10.1007/s42000-020-00253-3. Epub 2020 Oct 29.
3
In guidelines physicians trust? Physician perspective on adherence to medical guidelines for type 2 diabetes mellitus.
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.
优化 2 型糖尿病合并高心血管风险或已患心血管疾病人群使用胰高血糖素样肽-1 受体激动剂的障碍与策略:西班牙德尔菲共识。
Adv Ther. 2024 Sep;41(9):3569-3584. doi: 10.1007/s12325-024-02938-2. Epub 2024 Jul 22.
4
Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries-A Cross-Sectional Comparison.七个欧洲国家已批准并商业化的抗糖尿病药物(不包括胰岛素)——一项横断面比较
Pharmaceuticals (Basel). 2024 Jun 17;17(6):793. doi: 10.3390/ph17060793.
5
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective.具有心血管效应的新型抗糖尿病药物使用率低的原因——家庭医生视角
J Clin Med. 2024 Mar 12;13(6):1617. doi: 10.3390/jcm13061617.
6
Relationship Between Diet Quality and Glucose-Lowering Medication Intensity Among Adults With Type 2 Diabetes: Results From the CARTaGENE Cohort.2型糖尿病成人患者饮食质量与降糖药物使用强度之间的关系:CARTaGENE队列研究结果
CJC Open. 2023 Sep 29;6(1):20-29. doi: 10.1016/j.cjco.2023.09.015. eCollection 2024 Jan.
7
Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study.西班牙初级卫生保健中心就诊的2型糖尿病合并肥胖、虚弱或近期确诊患者对治疗指南建议的依从性:一项横断面研究。
Front Med (Lausanne). 2023 Mar 24;10:1138956. doi: 10.3389/fmed.2023.1138956. eCollection 2023.
8
Consensus from an expert panel on how to identify and support food insecurity during pregnancy: A modified Delphi study.专家小组就如何在怀孕期间识别和支持粮食不安全问题达成的共识:一项改良德尔菲研究。
BMC Health Serv Res. 2022 Oct 5;22(1):1231. doi: 10.1186/s12913-022-08587-x.
医生信任指南吗?医生对遵循2型糖尿病医学指南的看法。
Heliyon. 2020 Aug 31;6(8):e04803. doi: 10.1016/j.heliyon.2020.e04803. eCollection 2020 Aug.
4
Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.新兴市场和成熟市场 2 型糖尿病的疾病负担和相关成本:系统综述分析。
Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):785-798. doi: 10.1080/14737167.2020.1782748. Epub 2020 Jul 20.
5
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.糖尿病治疗惰性概述:患病率、成因及后果
Diabetes Spectr. 2020 Feb;33(1):8-15. doi: 10.2337/ds19-0029.
6
Abridged for Primary Care Providers.为初级保健提供者缩写。
Clin Diabetes. 2020 Jan;38(1):10-38. doi: 10.2337/cd20-as01.
7
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
8
Document on a comprehensive approach to type 2 diabetes mellitus.关于2型糖尿病综合治疗方法的文件。
Endocrinol Diabetes Nutr (Engl Ed). 2019 Aug-Sep;66(7):443-458. doi: 10.1016/j.endinu.2018.10.010. Epub 2019 Feb 28.
9
Global trends in diabetes complications: a review of current evidence.全球糖尿病并发症趋势:现有证据综述。
Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31.
10
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.2 型糖尿病患者高血糖治疗中的治疗惰性:系统评价。
Diabetes Obes Metab. 2018 Feb;20(2):427-437. doi: 10.1111/dom.13088. Epub 2017 Oct 1.